QSS
LAB icon

Quantitative Systematic Strategies’s Standard BioTools LAB Stock Holding History

Quantitative Systematic Strategies’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-40,927
Closed -$438K – 600
2015
Q4 		$438K Buy
+40,927
New +$402K 0.12% 211

Other funds holding LAB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
RFC
Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Quantitative Systematic Strategies's LAB Position: Q1 2016 in Review

Quantitative Systematic Strategies sold out of Standard BioTools (LAB) in Q1 2016, closing a stake of 40,927 shares — an estimated $438K sold.

Quantitative Systematic Strategies first reported a position in LAB in Q4 2015 and held it in 1 quarter. The position peaked at $438K in Q4 2015. 100 funds tracked by Wall St. Rank hold LAB as of Q1 2016.

  • Quantitative Systematic Strategies reported no remaining Standard BioTools position as of Q1 2016 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 40,927 Standard BioTools shares in Q1 2016, an estimated $438K.
  • Quantitative Systematic Strategies first reported a position in Standard BioTools in Q4 2015 and held it in 1 quarter.
  • Quantitative Systematic Strategies's Standard BioTools position peaked at $438K in Q4 2015.
  • 100 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2016.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2016, filed 22 Apr 2016.